Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Volatility is easy to overcome when there is a great earnings trend. Hexcel, Corp. ( HXL - Snapshot Report ) is a prime example. While shares have their ups and downs, the solid earnings history and upward estimate revisions warrant a deeper look at this Zacks #1 Rank (Strong Buy).
Company Description
Hexcel makes composites for lightweight, high-performance structural materials. Their products are used in for aerospace and industrials applications.
Net Income Doubles
On Oct 24 Hexcel reported its third-quarter results that showed a 20% jump in revenue, to $352 million. Net income jumped from $15.6 million, to $32.2 million.
After adjustments, EPS came out to $0.34, up from $0.20. That was 7 cents higher than the Zacks Consensus Estimate and gave the company its third consecutive earnings surprise and seventh in the past 8 quarters.
Raising the Bar
On top of the earnings beat Hexcel significantly raised its full-year guidance. Net income is now expected to come in between $1.18 and $1.23 per share, up from between $1.05 and $1.12.
Analysts quickly jumped on board as well. The average forecast for this year is up 11 cents to $1.23. Next year's Zacks Consensus Estimate is up 7 cents, to $1.39.
Last year Hexcel brought in $0.78 per share, so the growth rates are currently at 57% and 13%, respectively. The 3-5 year rate is just over 14%.
Valuations
Shares of HXL are going for 20 times this year's estimates and have a PEG ratio of 1.4. Neither is overly enticing but there is not much of a premium built in either. The same can be said for the P/S at 1.8 times and the P/B of 3.1.
The Chart
It is pretty easy to get lost in the noise when following stocks. But, if you take a step back and look at overall earnings trends, this is exactly what you like to see. Estimates moving up throughout the year and solid year over year growth.
Volatility in the stock will remain, but in the long run the great earnings trend should keep pushing shares higher. -
Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the Zacks Small Cap Trader service
Read the full reports :
Snapshot Report on HXL